GLP-1 Injection Costs: Compounded & Branded Pricing Guide

Last reviewed: May 18, 2026

Last updated: May 18, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

GLP-1 injection costs range from $129 to $600+ monthly depending on medication type, formulation, and dosage strength. Branded options like Ozempic and Wegovy typically cost $900–$1,300 per month without insurance, while compounded alternatives and microdose protocols offer more affordable entry points starting at $129 monthly.

Cost is only one factor in treatment selection. Clinical efficacy, individual metabolic factors, and long-term adherence matter equally. PlexusDx emphasizes transparent pricing paired with precision assessment tools so patients can have informed conversations with providers about which GLP-1 pathway—and price point—aligns with their health goals and budget constraints.

Branded GLP-1 Medications and Their Market Pricing

Branded semaglutide products (Ozempic for diabetes, Wegovy for weight management) are produced by Novo Nordisk and typically cost $900–$1,300 monthly at full retail price. Tirzepatide-based drugs (Mounjaro for diabetes, Zepbound for weight management) by Eli Lilly range $900–$1,400 monthly without insurance coverage.

Insurance coverage varies. Medicare Part D, most private plans, and employer-sponsored benefits may cover these medications with varying copays ($50–$500 per month), but formulary restrictions, prior authorization requirements, and step-therapy protocols often delay patient access or force higher out-of-pocket costs.

Cost Comparison Framework: Branded, Compounded, and Microdose Protocols

Understanding pricing across all GLP-1 options—from branded injectables to compounded formulations and microdose protocols—helps patients evaluate true affordability and accessibility. The framework below illustrates monthly cost ranges, pharmacy sourcing, and clinical considerations for each category.

GLP-1 Option	Typical Monthly Cost	Pharmacy Type	Key Consideration
Branded Semaglutide (Wegovy/Ozempic)	$900–$1,300	Retail pharmacy	Insurance coverage varies; may require prior auth
Branded Tirzepatide (Zepbound/Mounjaro)	$900–$1,400	Retail pharmacy	Newer option; formulary access still limited
Compounded Semaglutide Injection	$189	Licensed 503A pharmacy	Regulated compound; clinical guidance required
Compounded Tirzepatide Injection	$289	Licensed 503A pharmacy	Dual GIP/GLP-1 agonist; higher dosing cost
Microdose GLP-1 Protocol	$129	Licensed 503A pharmacy	Lower-dose entry point; suitable for certain patient profiles
Oral Semaglutide	$209+	Licensed 503A pharmacy	Alternative to injection; absorption varies
GLP-Squared Dual Compound	$289	Licensed 503A pharmacy	Combined semaglutide + tirzepatide; premium option

Why Compounded GLP-1 Medications Cost Less: Understanding the Regulatory Difference

Compounded GLP-1 medications are prepared by licensed 503A pharmacies under state regulation and FDA oversight. They cost substantially less than branded options because they avoid large-scale manufacturing, marketing, and distribution infrastructure that branded pharmaceuticals maintain, passing savings to patients.

Compounded formulations are not FDA-approved drugs in the branded sense but are regulated compounds prepared to USP standards. Patients choosing compounded options should work with qualified healthcare providers to ensure appropriate dosing, monitoring, and safety protocols are followed throughout treatment.

Insurance Coverage, Hidden Costs, and Long-Term Budget Planning

Insurance coverage for GLP-1 medications depends on diagnosis (diabetes vs. weight management), plan type, and medication status on the formulary. Copays range $50–$500 monthly, but deductibles, prior authorization fees, and specialty pharmacy markups can increase total cost. Many patients find out-of-pocket costs exceed insurance savings.

Beyond medication cost, patients should budget for provider visits, baseline labs, periodic monitoring (blood work, vital signs), and potential side effect management. Long-term treatment typically requires ongoing prescriptions; consider asking providers about cost assistance programs, patient savings cards, and whether compounded alternatives might reduce total treatment expense.

Who GLP-1 Treatment Is Appropriate For: Clinical and Safety Considerations

GLP-1 receptor agonists are indicated for type 2 diabetes management and, in certain formulations, for chronic weight management in individuals with obesity or overweight with weight-related conditions. Medical eligibility requires assessment of kidney function, thyroid status, pancreatitis history, and current medications by a qualified healthcare provider.

Contraindications include personal or family history of medullary thyroid carcinoma, history of multiple endocrine neoplasia type 2, severe gastrointestinal disease, and certain pregnancy considerations. Providers should evaluate each patient's metabolic profile, comorbidities, and financial capacity before recommending a specific GLP-1 protocol or price tier.

How PlexusDx Supports a More Personalized Approach

PlexusDx offers compounded semaglutide ($189/mo) and tirzepatide ($289/mo) from licensed 503A pharmacies, positioning affordability alongside clinical care. The Precision Peptide Genetic Test may help provide context regarding individual predispositions in key peptide pathways—including GIPR, FTO, and MC4R variants—which can support a more informed provider conversation about treatment selection.

The Precision Peptide Genetic Test reveals predispositions in peptide genetic pathways relevant to GLP-1 response mechanisms, but genetic testing does not predict exact medication response or guarantee specific outcomes. Results should be interpreted with a qualified healthcare provider to contextualize how individual genetic factors might inform treatment approach and monitoring expectations.

Cost decisions benefit from clinical insight. By understanding your baseline peptide pathway predispositions and discussing them with a provider, you can evaluate whether a microdose protocol ($129/mo), standard-dose compounded semaglutide ($189/mo), or a dual-compound option ($249/mo) aligns with both your health needs and budget. This conversation supports more confident, personalized treatment planning.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose GLP-1 Protocol is $129/mo flat. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

What does this guide say branded GLP-1 medications cost without insurance?

The article places branded semaglutide, meaning Ozempic for diabetes and Wegovy for weight management, and the tirzepatide-based drugs, Mounjaro for diabetes and Zepbound for weight management, in a roughly comparable four-figure monthly band at full retail. Its table lists the exact ranges alongside pharmacy type. The post stresses these are list prices before insurance, and that coverage changes them substantially.

Why does this article say compounded GLP-1 medications cost less than branded ones?

It attributes the gap to infrastructure rather than to the molecule: compounded preparations avoid the large-scale manufacturing, marketing and distribution costs branded pharmaceuticals carry, and those savings are passed along. The article is clear that compounded formulations are not FDA-approved drugs in the branded sense, and says patients choosing them should work with a qualified provider on monitoring and safety.

Beyond the medication itself, what costs does this guide tell readers to budget for?

It lists provider visits, baseline labs, periodic monitoring such as blood work and vital signs, and managing any side effects. The article also warns that deductibles, prior authorisation and specialty pharmacy markups can push total spend higher, and that many patients find out-of-pocket costs exceed what insurance saves them. It suggests asking providers about cost assistance and savings programs.

What does this article say determines whether insurance covers a GLP-1 at all?

It says coverage turns on the diagnosis, meaning diabetes versus weight management, plus the plan type and whether the medication sits on the formulary. The article adds that Medicare Part D, private plans and employer benefits may cover these drugs across a wide copay range, but that formulary restrictions, prior authorisation and step therapy often delay access or raise out-of-pocket costs.

What is the lowest-cost PlexusDx option named in this article?

The article names the Microdose GLP-1 Protocol as its lowest entry point, at $129/mo flat, dispensed from a licensed 503A compounding pharmacy. Its cost table describes that tier as a lower-dose starting option suitable for certain patient profiles rather than a universal recommendation. Whether it fits is presented as a clinical question for a provider, not purely a budgeting one.

Related Reading

• Glp 1 Cost 2
• Eden Glp 1 Cost Plexusdx
• Glp 1 Cost Plexusdx
• Glp 1 Cost

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.